Clinical trial · Interventional
Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors
Effects of Hands-on-Healing vs. Touch for Fatigue and Inflammation in Breast Cancer Survivors
NCT00440089CI-TRIAL-00003473completedPhase 2 / Phase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This randomized controlled trial examines the efficacy of hands-on-healing for fatigue and immune function in breast cancer survivors. Participants may be randomized to one of three groups: hands-on-healing, touch alone, or a control group.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Hands-on-Healing | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Multiple Fatigue Symptom Inventory
Secondary outcomes (2)
- measure
- Inflammatory Immune Markers
- measure
- Diurnal Cortisol Variability
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Premenopausal and postmenopausal women between the ages of 18 to 70 years. * Ability to give informed consent. * Breast cancer survivors who have undergone surgery, including lumpectomy and simple or total mastectomy, followed by chemotherapy or a combination of chemo- and radio-therapy. We have elected to study survivors instead of patients actively undergoing treatment to alleviate subject burden and risk during this protocol. * Stage I to III breast cancer survivors. * Breast cancer survivors who have finished their chemotherapy and/or radiotherapy at least one month prior to 60 months prior. * Breast cancer survivors with above-normative levels of fatigue. Exclusion Criteria: * Breast cancer patients who are currently receiving or who are scheduled to receive radiation or chemotherapy during the course of this intervention study. * Patients with current major depression, current or history of prior bipolar illness, currently on psychotropic medications. * Patients with other diseases that are known to induce fatigue (e.g., thyroid disorder; sleep disorders). * Patients with other inflammatory diseases that affect cytokine levels. * Patients with a history of other cancers, and stage IV breast cancer. * Patients undergoing current chemotherapy and/or radiotherapy. * Men with breast cancer. * Substance abuse/dependence. * Continued use of another biofield-based intervention (e.g., Reiki, Qi-Gong, Healing Touch, Therapeutic Touch, Johrei).
References
Publications (0)
Data not yet available
No reference posted for this study.